[Prognosis and results of radiotherapy of esophageal cancer with the use of radiomodifiers].
The paper is concerned with a retrospective analysis of the results of therapy of 277 esophageal cancer patients who received radiotherapy alone or in combination with radiomodifying agents depending on the results of clinico-instrumental investigations. Correlation of immediate effectiveness of radiation therapy and duration of a case history, macroscopic type of growth of a tumor, its dissemination, a degree of tumor regression at a dose of 35-40 Gy, the frequency and severity of radiation esophagitides was confirmed. A degree of the influence of these factors was less marked in the use of radiation therapy combined with radiomodifying agents. Life duration is proportional to a degree of tumor regression achieved by the end of a radical course of radiation therapy.
Isaev
I G
IG
Goldobenko
G V
GV
Tkachev
S I
SI
D002294:Carcinoma, Squamous Cell / Q000628:therapy; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000628:therapy*; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008875:Middle Aged; D011379:Prognosis; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011867:Radioisotope Teletherapy
D011838:Radiation-Sensitizing Agents; D008795:Metronidazole
Prognoz i rezul'taty luchevoĭ terapii bol'nykh rakom pishchevoda pri primenenii radiomodifikatorov.